Innovative CAR-T cell therapy receives FDA Breakthrough Therapy designation
March 26, 2026
March 26, 2026
ST. LOUIS, Missouri, March 26 -- The Washington University School of Medicine posted the following news release:
* * *
Innovative CAR-T cell therapy receives FDA Breakthrough Therapy designation
*
A cell-based immunotherapy designed to treat rare and aggressive types of blood cancer has been granted Breakthrough Therapy designation by the U.S. Food and Drug Administration (FDA). Developed by researchers at Washington University School of Medici . . .
* * *
Innovative CAR-T cell therapy receives FDA Breakthrough Therapy designation
*
A cell-based immunotherapy designed to treat rare and aggressive types of blood cancer has been granted Breakthrough Therapy designation by the U.S. Food and Drug Administration (FDA). Developed by researchers at Washington University School of Medici . . .